Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117407) titled 'A randomized controlled clinical study comparing the safety and efficacy of PRP alone and PRP combined with a spectral therapy instrument in the treatment of osteoarthritis' on Jan. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Sixth People's Hospital
Condition:
Osteoarthritis
Intervention:
Control group:Under ultrasound guidance, PRP injection is administered into the diseased joint, with 2-3ml per injection, once a week, for a continuous 3-week period, constituting one course of treatment.
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 20...